Client: Grupo Vargas
Country: El Salvador
Sector: Pharmaceuticals
Value: Undisclosed
Completion: December 2023
Description: BroadSpan Capital acted as exclusive financial advisor to Grupo Vargas and its shareholders on the sale of 100% of the outstanding shares of
Laboratorios Arsal, S.A. (“Arsal”) to Calox de Costa Rica, S.A. (“Calox”).